Literature DB >> 19170769

Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology.

Katsuhisa Kawai1, Yui Iwamae, Masaki Yamaga, Minoru Kiyota, Hiroko Ishii, Hajime Hirata, Yoshimi Homma, Hitoshi Yagisawa.   

Abstract

There is a class of GTPase activating proteins for the Rho family GTPases (RhoGAPs) that contain the steroidogenic acute regulatory protein (STAR)-related lipid transfer (START) domain. In mammals three genes encode such proteins and they are designated START-GAP1-3 or deleted in liver cancer 1-3 (DLC1-3). In this study, we examined the intracellular localization and roles of START-GAP1/DLC1 in cell motility. Immunofluorescence microscopic analysis of NRK cells and HeLa cells revealed that START-GAP1 was localized in focal adhesions. Amino acid residues 265-459 of START-GAP1 were found to be necessary for focal adhesion targeting and we name the region "the focal adhesion-targeting (FAT) domain." It was previously known that ectopic expression of START-GAP1 induced cell rounding. We demonstrated that the FAT domain of START-GAP1 was partially required for this morphological change. Furthermore, expression of this domain in HeLa cells resulted in dissociation of endogenous START-GAP1 from focal adhesions as a dominant negative modulator, reducing cell migration and spreading. Taken together, START-GAP1 is targeted to focal adhesions via the FAT domain and regulates actin rearrangement through down-regulation of active RhoA and Cdc42. Its absence from focal adhesions could, therefore, cause abnormal cell motility and spreading.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19170769     DOI: 10.1111/j.1365-2443.2008.01265.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  12 in total

1.  The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.

Authors:  Pratima Basak; Rachelle Dillon; Heather Leslie; Afshin Raouf; Michael R A Mowat
Journal:  BMC Cancer       Date:  2015-09-09       Impact factor: 4.430

2.  A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma.

Authors:  Myriam Loyo; Mariana Brait; Myoung S Kim; Kimberly L Ostrow; Chunfa C Jie; Alice Y Chuang; Joseph A Califano; Nanette J Liégeois; Shahnaz Begum; William H Westra; Mohammad O Hoque; Qian Tao; David Sidransky
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

3.  DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism.

Authors:  Xuyu Yang; Nicholas C Popescu; Drazen B Zimonjic
Journal:  Cancer Res       Date:  2011-03-03       Impact factor: 12.701

Review 4.  From mechanical force to RhoA activation.

Authors:  Elizabeth C Lessey; Christophe Guilluy; Keith Burridge
Journal:  Biochemistry       Date:  2012-09-10       Impact factor: 3.162

5.  The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motility.

Authors:  Bassem D Khalil; Samer Hanna; Bechara A Saykali; Sally El-Sitt; Anita Nasrallah; Daniel Marston; Marwan El-Sabban; Klaus M Hahn; Marc Symons; Mirvat El-Sibai
Journal:  Exp Cell Res       Date:  2013-12-10       Impact factor: 3.905

6.  Nuclear-targeted deleted in liver cancer 1 (DLC1) is less efficient in exerting its tumor suppressive activity both in vitro and in vivo.

Authors:  Lo-Kong Chan; Frankie Chi Fat Ko; Karen Man-Fong Sze; Irene Oi-Lin Ng; Judy Wai Ping Yam
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

7.  Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma.

Authors:  Lo-Kong Chan; Yung-Tuen Chiu; Karen Man-Fong Sze; Irene Oi-Lin Ng
Journal:  Oncotarget       Date:  2015-08-28

Review 8.  The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction.

Authors:  Olga Soriano; Marta Alcón-Pérez; Miguel Vicente-Manzanares; Esther Castellano
Journal:  Genes (Basel)       Date:  2021-05-27       Impact factor: 4.096

9.  Uncovering the rare variants of DLC1 isoform 1 and their functional effects in a Chinese sporadic congenital heart disease cohort.

Authors:  Bin Lin; Yufeng Wang; Zhen Wang; Huilian Tan; Xianghua Kong; Yang Shu; Yuchao Zhang; Yun Huang; Yufei Zhu; Heng Xu; Zhiqiang Wang; Ping Wang; Guang Ning; Xiangyin Kong; Guohong Hu; Landian Hu
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Dlc1 interaction with non-muscle myosin heavy chain II-A (Myh9) and Rac1 activation.

Authors:  Mohammad G Sabbir; Rachelle Dillon; Michael R A Mowat
Journal:  Biol Open       Date:  2016-04-15       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.